Orchestra BioMed Holdings, Inc. (OBIO) has a consensus analyst rating of Buy, based on 4 analysts covering the stock. Of those, 3 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for OBIO is $12.00, representing a +166.1% upside from the current price of $4.51. Price targets range from a low of $12.00 to a high of $12.00.
